Bottom line
SHSSX vs HRTS: the short answer
SHSSX (Blackrock Health Sciences Opportunities Portfolio) and HRTS (Tema Heart & Health ETF) share a meaningful slice of their top holdings — about 61% by weight.
But SHSSX is far broader, holding 155 positions to 45 for HRTS, so beyond the top names it adds exposure HRTS doesn't have.
HRTS is cheaper at 0.75% vs 0.86% — a difference of $11 a year per $10,000 invested.
Over one year, HRTS returned +23.6% vs +16.3% for SHSSX.
Updated Nov 19, 2026
SHSSX vs HRTS side by side
| SHSSX | HRTS | |
|---|---|---|
| Type | Mutual fund | ETF |
| Fund family | BlackRock | Innovator |
| Category | Health Care Sector | Health Care Sector |
| Expense ratio | 0.86% | 0.75% |
| Annual cost per $10k | $86 | $75 |
| 10-yr cost on $10k (prospectus) | $1,061 | $1,168 |
| Max front load | 0% | None |
| 12b-1 fee | 0% | 0% |
| 1-yr return | +16.3% | +23.6% |
| 5-yr return (annualized) | +5.9% | — |
| 10-yr return (annualized) | +9.8% | — |
| Best quarter | — | +15.8% |
| Worst quarter | — | −12.4% |
| Net assets (fund) | $5.9B | $51.9M |
| Number of holdings | 155 | 45 |
| Portfolio turnover | 49% | 4% |
| Returns as of | Dec 31, 2025 | Dec 31, 2025 |
Source: SEC Form N-PORT and fund prospectuses
Holdings overlap
16 of SHSSX's top 25 holdings also appear in HRTS's top 25.
| Holding | SHSSX | HRTS |
|---|---|---|
| Eli Lilly & Company | 12.29% | 11.52% |
| Johnson & Johnson | 8.77% | 3.59% |
| Unitedhealth Group Inc | 6.10% | 5.24% |
| Merck & Company Inc | 4.94% | 4.27% |
| Gilead Sciences Inc | 4.19% | 3.43% |
| Abbvie Inc | 3.94% | 2.40% |
| Amgen Inc | 3.37% | 1.91% |
| Thermo Fisher Scientific Inc | 3.02% | 3.97% |
| Vertex Pharmaceuticals Inc | 2.74% | 2.93% |
| Edwards Lifesciences Corp | 2.51% | 1.75% |
| Danaher Corp | 2.00% | 2.66% |
| Abbott Laboratories | 1.97% | 2.61% |
| Teva Pharmaceutical Industries Ltd | 1.87% | 2.06% |
| Astrazeneca Plc | 1.21% | 4.00% |
| Revolution Medicines Inc | 0.96% | 3.33% |
Source: SEC Form N-PORT
SHSSX top 10
- Eli Lilly & Company — 12.29%
- Johnson & Johnson — 8.77%
- Unitedhealth Group Inc — 6.10%
- Merck & Company Inc — 4.94%
- Gilead Sciences Inc — 4.19%
- Abbvie Inc — 3.94%
- Amgen Inc — 3.37%
- Thermo Fisher Scientific Inc — 3.02%
- Vertex Pharmaceuticals Inc — 2.74%
- Pfizer Inc — 2.61%
HRTS top 10
- Eli Lilly & Co — 11.52%
- UnitedHealth Group Inc — 5.24%
- Novo Nordisk A/S — 5.24%
- Roche Holding AG — 4.50%
- Merck & Co Inc — 4.27%
- AstraZeneca PLC — 4.00%
- Thermo Fisher Scientific Inc — 3.97%
- Johnson & Johnson — 3.59%
- Gilead Sciences Inc — 3.43%
- Novartis AG — 3.38%
FAQ
What is the difference between SHSSX and HRTS?
Which is cheaper, SHSSX or HRTS?
Should I own both SHSSX and HRTS?
Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.